Cargando…
Development of Indole Alkaloid-Type Dual Immune Checkpoint Inhibitors Against CTLA-4 and PD-L1 Based on Diversity-Enhanced Extracts
Cancer immunotherapy involves the use of the immune system for cancer treatment. Recently, immune checkpoint-blocking antibodies have become integral for the treatment of some cancers. However, small molecules exhibit advantages over monoclonal antibody drugs, such as cell penetration, long half-lif...
Autores principales: | Suzuki, Yoshihide, Ichinohe, Keisuke, Sugawara, Akihiro, Kida, Shinya, Murase, Shinya, Zhang, Jing, Yamada, Osamu, Hattori, Toshio, Oshima, Yoshiteru, Kikuchi, Haruhisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630621/ https://www.ncbi.nlm.nih.gov/pubmed/34858943 http://dx.doi.org/10.3389/fchem.2021.766107 |
Ejemplares similares
-
Two New Terpenes Isolated from Dictyostelium Cellular Slime Molds
por: Sasaki, Hitomi, et al.
Publicado: (2020) -
Analysis of alkaloids (indole alkaloids, isoquinoline alkaloids, tropane alkaloids)
por: Dey, Prasanta, et al.
Publicado: (2020) -
Marine Indole Alkaloids
por: Netz, Natalie, et al.
Publicado: (2015) -
Beyond CTLA-4 and PD-1, the Generation Z of Negative Checkpoint Regulators
por: Le Mercier, Isabelle, et al.
Publicado: (2015) -
Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4
por: Qin, Shuang, et al.
Publicado: (2019)